Screener
Integra LifeSciences IART Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total costs and expenses | 399,476 | 928,279 | 779,924 | 1,326,429 |
| Operating income (loss) | 19,285 | (512,674) | 30,755 | (528,171) |
| Interest income | 4,267 | 4,710 | 8,372 | 9,130 |
| Interest expense | (22,994) | (21,042) | (45,459) | (39,857) |
| Other income (expense), net | 4,186 | (1,946) | 8,665 | (2,090) |
| Income (loss) before income taxes | 4,744 | (530,952) | 2,333 | (560,988) |
| Provision (benefit) for income taxes | 262 | (46,879) | 2,467 | (51,622) |
| Net income (loss) | $4,482 | $(484,073) | $(134) | $(509,366) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's interest expense?
- Integra LifeSciences (IART) reported interest expense of $22.99M in Q2 2026.
- How has Integra LifeSciences's interest expense changed year-over-year?
- Integra LifeSciences's interest expense increased by 9.3% year-over-year, from $21.04M to $22.99M.
- What is the long-term trend for Integra LifeSciences's interest expense?
- Over 4 years (2021 to 2025), Integra LifeSciences's interest expense has grown at a 14.4% compound annual growth rate (CAGR), from $50.4M to $86.26M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Integra LifeSciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude